Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Visualized Experiments

• Publication date

  2018-03-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3791/56564PMID 29608150PMCID PMC5931769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea

  2016cited by this paper
• Mouse Auditory Brainstem Response Testing.

  2016cited by this paper
• Whole Mount Dissection and Immunofluorescence of the Adult Mouse Cochlea.

  2016cited by this paper
• Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation

  2011cited by this paper
• NOX3 NADPH Oxidase Couples Transient Receptor Potential Vanilloid 1 to Signal Transducer and Activator of Transcription 1-Mediated Inflammation and Hearing Loss

  2011cited by this paper
• Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

  2008cited by this paper
• Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

  2007cited by this paper
• Oxaliplatin-related neurotoxicity: how and why?

  2006cited by this paper
• Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors

  2006cited by this paper
• Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.

  2006cited by this paper
• NOX3, a Superoxide-generating NADPH Oxidase of the Inner Ear*

  2004cited by this paper
• Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment

  2004cited by this paper
• Mechanisms of Apoptosis Induced by Cisplatin in Marginal Cells in Mouse Stria Vascularis

  2004cited by this paper
• Cisplatin and platinum drugs at the molecular level. (Review).

  2003cited by this paper
• Cryoembedding and sectioning of cochleas for immunocytochemistry and in situ hybridization.

  2001cited by this paper
• Effect of protective agents against cisplatin ototoxicity.

  2000cited by this paper
• Comparative Adverse Effect Profiles of Platinum Drugs

  1995cited by this paper
• Rat as a Potential Model for Hearing Loss in Biotinidase Deficiency

  1991cited by this paper
• 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors

  1987cited by this paper
• Subclasses of external adenosine receptors.

  1980cited by this paper

• Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation

  2025cites this paper
• Do Disinfectants Induce Ototoxicity and Cause Structural Damage to the Inner Ear?

  2025cites this paper
• Overview of Spanlastics: A Groundbreaking Elastic Medication Delivery Device with Versatile Prospects for Administration via Various Routes.

  2024cites this paper
• Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity

  2023cites this paper
• Testing the In Vitro Product Performance of Mucosal Drug Products: View of the USP Expert Panel

  2023cites this paper
• Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss

  2021cites this paper
• Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity

  2020cites this paper
• Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss

  2019cites this paper
• Local Drug Delivery for Prevention of Hearing Loss

  2019cites this paper
• Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss

  2019cites this paper
• The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss

  2018cites this paper